Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

229 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Precision Medicine in Osteosarcoma: MATCH Trial and Beyond.
Tirtei E, Campello A, Asaftei SD, Mareschi K, Cereda M, Fagioli F. Tirtei E, et al. Among authors: cereda m. Cells. 2021 Jan 31;10(2):281. doi: 10.3390/cells10020281. Cells. 2021. PMID: 33572496 Free PMC article. Review.
Omic approaches to pediatric bone sarcomas.
Tirtei E, Cereda M, De Luna E, Quarello P, Asaftei SD, Fagioli F. Tirtei E, et al. Among authors: cereda m. Pediatr Blood Cancer. 2020 Feb;67(2):e28072. doi: 10.1002/pbc.28072. Epub 2019 Nov 17. Pediatr Blood Cancer. 2020. PMID: 31736201 Review.
HaTSPiL: A modular pipeline for high-throughput sequencing data analysis.
Morandi E, Cereda M, Incarnato D, Parlato C, Basile G, Anselmi F, Lauria A, Simon LM, Laurence Polignano I, Arruga F, Deaglio S, Tirtei E, Fagioli F, Oliviero S. Morandi E, et al. Among authors: cereda m. PLoS One. 2019 Oct 15;14(10):e0222512. doi: 10.1371/journal.pone.0222512. eCollection 2019. PLoS One. 2019. PMID: 31613890 Free PMC article.
FOXA1 regulates alternative splicing in prostate cancer.
Del Giudice M, Foster JG, Peirone S, Rissone A, Caizzi L, Gaudino F, Parlato C, Anselmi F, Arkell R, Guarrera S, Oliviero S, Basso G, Rajan P, Cereda M. Del Giudice M, et al. Among authors: cereda m. Cell Rep. 2022 Sep 27;40(13):111404. doi: 10.1016/j.celrep.2022.111404. Cell Rep. 2022. PMID: 36170835 Free PMC article.
Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1+ Chemoresistant Lung Cancer Cells.
Rotolo R, Leuci V, Donini C, Galvagno F, Massa A, De Santis MC, Peirone S, Medico G, Sanlorenzo M, Vujic I, Gammaitoni L, Basiricò M, Righi L, Riganti C, Salaroglio IC, Napoli F, Tabbò F, Mariniello A, Vigna E, Modica C, D'Ambrosio L, Grignani G, Taulli R, Hirsch E, Cereda M, Aglietta M, Scagliotti GV, Novello S, Bironzo P, Sangiolo D. Rotolo R, et al. Among authors: cereda m. Clin Cancer Res. 2023 Feb 1;29(3):621-634. doi: 10.1158/1078-0432.CCR-22-0761. Clin Cancer Res. 2023. PMID: 36165915 Free PMC article.
A Comprehensive Bioinformatics Analysis of UBE2C in Cancers.
Dastsooz H, Cereda M, Donna D, Oliviero S. Dastsooz H, et al. Among authors: cereda m. Int J Mol Sci. 2019 May 7;20(9):2228. doi: 10.3390/ijms20092228. Int J Mol Sci. 2019. PMID: 31067633 Free PMC article.
Integrative genomic and transcriptomic analyses illuminate the ontology of HER2-low breast carcinomas.
Berrino E, Annaratone L, Bellomo SE, Ferrero G, Gagliardi A, Bragoni A, Grassini D, Guarrera S, Parlato C, Casorzo L, Panero M, Sarotto I, Giordano S, Cereda M, Montemurro F, Ponzone R, Crosetto N, Naccarati A, Sapino A, Marchiò C. Berrino E, et al. Among authors: cereda m. Genome Med. 2022 Aug 29;14(1):98. doi: 10.1186/s13073-022-01104-z. Genome Med. 2022. PMID: 36038884 Free PMC article.
229 results